Gyre Therapeutics, Inc. (GETTEX:L9S) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Augustine Lawlor Other companies: PRF Technologies Ltd. (Director · Since at least Mar 18, 2026); Cypherpunk Technologies Inc. (Chief Operating Officer · Since at least Jan 20, 2017); Globeimmune Inc (Director · Jul 1, 2014 – Mar 18, 2016 · Past); Cardiovascular Systems Inc (Director · Aug 31, 2012 – Apr 27, 2023 · Past); Human Genome Sciences Inc (Director · Oct 10, 2011 – Jul 30, 2012 · Past) | Director · Aug 20, 2015 – Aug 31, 2023 · Past |
| Charles A Blixt Other companies: Lamb Weston Holdings, Inc. (Director · Nov 8, 2016 – Dec 23, 2024 · Past); Krispy Kreme Doughnuts Inc (Director · Sep 12, 2006 – Jul 27, 2016 · Past) | Director · Apr 11, 2006 – Aug 14, 2015 · Past |
| Eddie Williams Other companies: BioAtla, Inc. (Director · Since at least Dec 16, 2021); BiomX Inc. (Director · Oct 12, 2023 – Apr 14, 2025 · Past) | Director · Jan 2, 2018 – Jan 7, 2022 · Past |
| David M Epstein Other companies: Black Diamond Therapeutics, Inc. (SEE REMARKS, Director · Jan 29, 2020 – Jun 27, 2023 · Past) | Director · Since at least Aug 6, 2024 |
| Geoffrey M D Ling Other companies: Celularity Inc. (Director · Since at least Aug 31, 2023) | Director · Jan 15, 2020 – Jan 7, 2022 · Past |
| Julia R Brown Other companies: Albireo Pharma Inc (Director · Apr 24, 2012 – Jun 7, 2018 · Past) | Director · May 12, 2010 – Aug 14, 2015 · Past |
| Peter A Zorn Other companies: Albireo Pharma Inc (Chief Corp. Officer, GC & Sec · Nov 3, 2016 – Aug 21, 2017 · Past) | SVP, Lgl Affrs, GC & Secretary · Dec 19, 2007 – Jan 17, 2013 · Past |
| Charles C Wu | Chief Executive Officer, Director · Oct 30, 2023 – Nov 20, 2023 · Past |
| Claire Weston | Board Member · Since at least Jul 16, 2026 |
| Dan Weng | Board Member · Since at least Aug 18, 2025 |
| David A Hosford | VP, Clin Dev & Reg Affairs · Jan 23, 2014 – Jan 23, 2014 · Past |
| David Zhang | Chief Business · Since at least Jan 5, 2026 |
| Edwin Madison | Chief Scientific Officer · Aug 20, 2015 – Oct 22, 2015 · Past |
| Gordon G. Carmichael | Board Member · Since at least Oct 30, 2023 |
| Grant E Blouse | Chief Scientific Officer · Jul 12, 2021 – Aug 9, 2022 · Past |
| Han Ying | Chief Executive Officer, Director · Oct 30, 2023 – Aug 14, 2024 · Past |
| Jialiang Wang | Executive Vice President, General Manager · Since at least Nov 5, 2026 |
| Jing Liu | Senior Vice President - Platform Chemistry · Since at least Nov 5, 2026 |
| Joshua Bergmann | General Counsel and Corporate Secretary · Since at least Nov 5, 2026 |
| Leslie Robinson | Vice President - Intellectual Property and Licensing · Since at least Nov 5, 2026 |
| Liang Zhao | VP Corporate Controller · Since at least Nov 5, 2026 |
| Mark Marino | Senior Vice President-Clinical Development · Since at least Nov 5, 2026 |
| Mauri K Hodges | Treasurer, CFO · May 4, 2012 – Aug 14, 2015 · Past |
| Maxwell Kirkby | Board Member · Since at least Jul 16, 2026 |
| Michael Plewe | Senior Vice President - Medicinal Chemistry · Since at least Nov 5, 2026 |
| Nassim Usman | Director · Feb 8, 2021 – Jun 28, 2024 · Past |
| Patrick C Rock | Secretary, GC · Aug 14, 2015 – Aug 14, 2015 · Past |
| Ping Zhang | Chairman · Since at least Jan 5, 2025 |
| Renate Parry | Director · Since at least Oct 30, 2023 |
| Rodney L. Nussbaum | Board Member · Since at least Mar 20, 2024 |
| Ruoyu Chen | Chief Information Officer · Since at least Oct 30, 2023 |
| Seth Goldblum | Senior Vice President - Corporate Development · Since at least Nov 5, 2026 |
| Thomas Eastling | Chief Financial Officer · Since at least Dec 26, 2022 |
| Weiguo Ye | Chief Operating Officer · Since at least Oct 30, 2023 |
| William S Caldwell | SVP - Drug Discovery and Dev. · Jan 9, 2009 – Sep 20, 2011 · Past |
| Ying Luo | Chief Executive Officer, Director · Since at least Dec 26, 2022 |
| Yue Xiong | Chief Scientific Officer · Since at least May 4, 2026 |